Growth Promotion and Turner-Specific Bone Age after Therapy with Growth Hormone and in Combination with Oxandrolone: When Should Therapy Be Started in Turner Syndrome?

Hormone Research in Paediatrics

Volumn 47, Issue 3, 1997, Pages 102-109

  Joss, E E ^a   Mullis, P E ^a   Werder, E A ^b   Partsch, C J ^c   Sippell, W G ^c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Bone age; Growth hormone; Height velocity; Oxandrolone; Turner syndrome

Indexed keywords

HORMONE; HUMAN GROWTH HORMONE; OXANDROLONE;

AGE; ARTICLE; BODY HEIGHT; BONE AGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GROWTH RATE; GROWTH STIMULATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TURNER SYNDROME;

EID: 0031051026     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185443     Document Type: Article

References (38)

1. Raili S, Moore WV, Van Vliet G, Kaplan SL: Growth-stimulating effects of human growth hormone therapy in patients with Turner syndrome. J Pediatr 1986:109:944-949.
2. Buchanan CR, Law CM, Milner RDG: Growth hormone in short, slowly growing children and those with Turner's syndrome. Arch Dis Child 1987;62:912-916.
3. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S, Compton P, France J, Gotlin RW, Kuntze J, Lippc BM, Mahoney PC, Moore WV, New MI, Saenger P, Sybert V: Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1988:113:393-400.
4. Vanderschueren-Lodeweyckx M. Massa G. Maes M. Craen M. Van Vliet G. Heinrichs C. Malvaux P: Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner’s syndrome. J Clin Endocrinol Metab 1990:70:122-126.
5. Massa G. Vanderschueren-Lodeweyckx M. Craen M. Vendewcghe M. Van Vliet G: Growth treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests. Eur J Pediatr 1991:150:460-463.
6. Sippell WG. Partsch CJ. Steinkamp H: Biosynthetic growth hormone (Genotropin) therapy in girls with Ullrich-Turner-syndrome (UTS): in Ranke MB. Rosenfeld RG (eds): Turner Syndrome: Growth Promoting Therapies. Amsterdam. Excerpta Medica. 1991. pp 237-240.
7. Rongcn-Westerlaken C, van Es A, Wit JM, Otten BJ, De Muinck M, Kcizer-Schrama SMPF, Draver NM, Oostdijk W, Dlemarrc van dcr M, Wall HA, Gons MH, Waelkens JJJ, Van den Brande JL: Growth hormone therapy in Turner's syndrome: Impact of injection frequency and initial bone age. Am J Dis Child 1992:146: 817-820.
8. Rongen-Westerlakcn C. Wit JM. Keizer-Schrama SMP, Otten BJ, Oostdijk W, Wall HA, Gons HM, Bot A, Van den Brande JL: Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Eur J Pediatr 1992: 151:477-481.
9. Rosenfeld RG, Franc J, Altie KM, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, Saenger P, Johanson AJ: Six year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1992:121:49-55.
10. Stahnke N. Slubbe P. Keller E: Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome. Horm Res I992:37(suppl 2):37-46.
11. Massa G. Maes M. Heinrichs C. Vandeweghe M. Craen M. Vanderschueren-Lodeweyckx M: Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner’s syndrome. Clin Endocrinol 1993:38:253-260.
12. Knudtzon J. Aarskog D: Results of two years of growth hormone treatment followed by combined growth hormone and oestradiol in Turner syndrome. Horm Res 1993;39(suppl 2):7-17.
13. Lenko HL, Hakulincn A, Kaar ML, Maenpaa J, Makelii AL, Sipla I: Effects of conventional dose growth hormone therapy for two years on height velocity and height prognosis in girls with Turner syndrome. Horm Res 1993,39 (suppl 2):3-6.
14. Takano K. Shizume K. Hibi I. Ogawa M. Okada Y. Suwa S. Tanaka T: Growth hormone treatment in Turner syndrome: Results of a multicentrc study in Japan. Horm Res 1993:39 (suppl 2):37-41.
15. Nienhuis HE, Rongcn-Wcstcrlakcn C, Wii JM, Itten BJ, Keizcr-Schrama SMP, Drayer NM, Waal HA, Vuls-nia T, Oosldijk W, Waclkens JJJ: Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. I lorm Res I993;39(suppl 2):31-36.
16. Chaussain JL. Gendrel C. Job B. Ducrel JP: Optimization ofthedoseofgrowth hormone in girls with Turner syndrome: in Hibi I. Takano K (cds): Basie and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica. 1993, pp 273-278.
17. Job JC: How sex steroid can modify the effect of growth hormone on growth in Tumer syndrome: in Hibi I. Takano K (eds): Basic and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica. 1993. pp 279-286.
18. Stephure DK. Holland FJ. Alexander D. Bailey J. Best T. Boulton BC. Bruce GA. Clarsen C. Collu R. Couch R. Curtis J. Danneman D. Dean H, Ehrlich.R. Guyda H. Jenner M. Khou-ry K. Kitzcn K. MacMillan A. Marchall HP. Morrison K. Perlman K. Rovet J. Salisbury S. Sochett E, Stewart L, Szots F, TJ, Vander Meulen J, Van Vliet G: Human growth hormone and low dose ethinyl estradiol treatment in Turner syndrome: A prospective randomized controlled trial to final height: in Hibi 1. Takano K (cds): Basic and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica, 1993. pp 287-291.
19. Nilsson KO. Albcrtsson-Wikland K. Aronson S. Gustafsson J. Hagenas L. Hager A. Ivarsson SA. Karlberg J. Kristrom B. Moell C. Ritzen M. Tuvcmo T. Wattsgard C. Westgren U. West-phal O. Aman J: Long-term results of combination treatment with growth hormone, oxandro-lone and ethinyl estradiol in girls with Turner syndrome: in Hibi I. Takano K (eds): Basic and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica. 1993. pp 303-310.
20. Stahnke N. Stubbe P. Attanasio A. Reinhardt D. Partsch CJ. Sippell WG: GH therapy alone or together with oxandrolone in 212 patients with Turner syndrome: The German experience: in Hibi I. Takano K (eds): Basic and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica. 1993. pp 315-322.
21. Spoudcas HA. Motta RM. Stanhope R. Hind-marsh PC. Brook CGD: Therapeutic options for promoting growth in Turner syndrome: in Hibi 1. Takano K (cds): Basic and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica, 1993, pp 323-326.
22. Roscnfcld RG: Long-term results of GH therapy in Turner syndrome; in Hibi I, Takano K (eds): Basic and Clinical Approach to Turner Syndrome. Amsterdam. Excerpta Medica. 1993. pp 339-344.
23. Rochiccioli P. Battin J. Bertrand AM. Bost M. Cabrol S. Le Bouc Y. Chaussin JL. Chatclain P. Job JC. Leheup B. Pierson M. Mariani R. Ponte C. Rappaport R: Tailles finales des syndromes de Tumer t raites par hormone dc crois-sancc. Arch Pediatr 1994:1:395-362.
24. Van Teunenbroek A, Keizer-Schrama S, Stijnen T, Drop S: Constant versus a two step increase of the growth hormone dose in Turners syndrome: Three year auxological results. 33rd Annual Meeting of the ESPE. Horm Res 1994:41:abstr 127.
25. Naeraa RW. Nielsen J. Kastrup KW: Growth hormone and 17-5 oestradiol treatment of Turner girls - 2-year results. Eur J Pediatr 1994;153:72-77.
26. De Schepper J. Caen M. Massa G. Heinrichs C. Maes M. Du Caju M. Rausin L. Bourguignon JP: Growth hormone therapy in Turner’s syndrome: One versus two daily injections. J Clin Endocrinol Metab 1994;79:489-494.
27. Joss EE, Zuppinger KA: Oxandrolone in girls with Tumer’s syndrome: A pair-matched controlled study up to final height. Acta Paediatr Scand 1984;73:674-679.
28. Joss EE: Anabolic steroids in girls with Turner’s syndrome. Acta Paediatr Scand 1988:77 (suppl 343):38-42.
29. Naeraa RW. Nielsen J. Pedersen IJ. Sorensen K: Effect of oxandrolone on growth and final height in Turner’s syndrome. Acta Paediatr Scand 1990;79:784-789.
30. Crock P. Wenher GA. Wettcnhall HNB: Oxandrolone increases final height in Turner syndrome. J Pediatr Child Health 1990:26:221-224.
31. Ranke MB. Chavez-Mcyer H. Blank B. Frisch II, Hauslcr G: Spontaneous growth and bone age development in Turner syndrome: Results of a multicentric study 1990; in Ranke MB. Rosenfeld RG (cds): Turner Syndrome: Growth Promoting Therapies. Amsterdam, Excerpta Medica. 1991, pp 101-106.
32. Tanner JM. Whitehouse RM. Cameron N. Marshall WA. Healy MJR. Goldstein H: Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method). New York. Academic Press. 1983.
33. Joss EE: Evaluation of hormonal treatment on lincargrowth and skeletal maturation: methods of predicting final height in Turner syndrome: in Ranke MB. Rosenfeld RG (eds): Turner Syndrome: Growth Promoting Therapies. Amsterdam. Excerpta Medica. 1991. pp 83-88.
34. Ranke MB. Plliiger H. Rosendahl W. Stubbe P. Endcrs H. Bierich JR. Majewski F: Turner syndrome: Spontaneous growth in 150 cases and review of the literature. Eur J Pediatr 1983; 141:81-88.
35. Lenko HL. Perheentupa J. Soderholm A: Growth in Tumer syndrome: Spontaneous and fluoxymestrone stimulated. Acta PediatrScand I979;68(suppl 227):57-63.
36. Naeraa RW, Eiken M, Lcgarth EG. Nielsen J: Prediction of final height in Turner's syndrome. Acta Paediatr Scand 1990:79:776-783.
37. David M, Dorche C, Rolland MO, Morel Y: Organisation of a screening network for T umer syndrome with blood spots taken at 9 months of age. 33rd Annual Meeting of the ESPE. Horm Res 1994;41:abslr 45.
38. Ranke MB, Price DA, Maes M, Albcrtsson-Wikland K, Lindberg A: Factors influencing final height to GH treatment in Turner syndrome: Results of the KABl-international Growth Study (KIGS). Int Syntp Turner Syndrome. Gothcburg. May 18-20, 1995. abstr 11.